Inhaled insulin superior to rosiglitazone in patients with uncontrolled type 2 diabetes

In the CONNECT trial, CGM users with type 2 diabetes not on insulin saw larger A1C reductions and more time in range than those using finger-stick testing.

Democrats won Congress, but with Trump’s veto, their best healthcare tools are funding bills, hearings and bipartisan deals.

CVS Health announced today that it is reorganizing into two publicly traded companies. The CEO spoke about working on "commercial agreements" between the two. Critics and competitors question how separate they will be.

South Dakota voters rejected Amendment I, which could have ended Medicaid expansion for approximately 31,000 residents if federal funding fell below 90%.

Christine Johnston says Medicaid plans have embraced biosimilars faster than commercial plans and challenges the idea that more expensive means better.

After more than 20 years at Humana, Jeremy Gaskill now leads nonprofit Geisinger Health Plan. The problems are the same, he says, the scale for solving them differs.

Jeremy Gaskill took the reins at the Geisinger Health Plan earlier this year after a long career at Humana. He discusses the similarities and differences between Geisinger and Humana and the advantages of a health plan that is part of a health system.

The retail pharmacies will be in one company and Aetna and CVS Caremark, the PBM, in another, according to news reports.